Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Glasgow-Blatschford Score Validation in Digestive Hemorrhage

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by University Hospital, Geneva.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01029626
First received: December 9, 2009
Last updated: NA
Last verified: October 2009
History: No changes posted
  Purpose

The purpose of this study is to validate the Glasgow-Blatchford score for the stratification of patients with upper gastro-intestinal hemorrhage. This score is easy to calculate. It is mainly based on the hemoglobin, blood pressure and blood urea. if the score is zero, the bleeding is very low risk and the gastrointestinal endoscopy may be delayed and performed as an outpatient.


Condition Intervention
Gastrointestinal Hemorrhage
Procedure: Endoscopy

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Glasgow-Blatschford Score Validation for Stratification of Patients With Digestive Hemorrhage

Resource links provided by NLM:


Further study details as provided by University Hospital, Geneva:

Primary Outcome Measures:
  • Comparison of length of stay between patients with score equal to zero and above zero [ Time Frame: june 2010 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Determination of the proportion of low risk upper gastrointestinal bleeding [ Time Frame: june 2010 ] [ Designated as safety issue: No ]

Estimated Enrollment: 64
Study Start Date: October 2009
Estimated Study Completion Date: March 2011
Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Endoscopy
If the Glasgow-Blatchford score is zero, the endoscopy is delayed as an outpatient
Procedure: Endoscopy
Realization of an upper GI endoscopy

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • To be admitted in the university hospital for a gastrointestinal hemorrhage (vomiting of red or black blood or melena)

Exclusion Criteria:

  • Age under 18
  • Pregnancy
  • Hemorrhage during hospitalisation
  • red rectal bleeding
  • No consent signed
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01029626

Contacts
Contact: Marc Girardin, MD +41223729340 marc.girardin@hcuge.ch

Locations
Switzerland
Geneva University Hospital Recruiting
Geneva, Switzerland, 1211
Contact: Marc Girardin, MD    +41223729340    marc.girardin@hcuge.ch   
Principal Investigator: Marc Girardin, MD         
Sub-Investigator: Jean-Marc Dumonceau, MD         
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Principal Investigator: Marc Girardin, MD Geneva University Hospital
  More Information

Publications:
Responsible Party: Marc Girardin Dr, Geneva University Hospital
ClinicalTrials.gov Identifier: NCT01029626     History of Changes
Other Study ID Numbers: 09-091
Study First Received: December 9, 2009
Last Updated: December 9, 2009
Health Authority: Switzerland: Ethikkommission

Additional relevant MeSH terms:
Gastrointestinal Hemorrhage
Hemorrhage
Digestive System Diseases
Gastrointestinal Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on November 25, 2014